Adams PLC - Final Results
Adams Plc
("Adams" or the "Company")
ANNUAL REPORT AND FINANCIAL STATEMENTS FOR THE YEAR ENDED
Adams Plc presents its annual report and audited financial results for the year ended
Highlights:
- Net assets at
- Net assets per share
- Loss after tax of
- Investments at
- Spend on new investments of
- Proceeds from investment realisations
- Cash at
- No part of the
"Elevated trade tensions with
In view of the above risks and uncertainties, your Board will continue to maintain a rigorous and highly selective investment approach, coupled with strict cost control with a view to delivering additional value for shareholders going forward. We remain confident in the underlying fundamentals, technologies and long-term potential for growth at the companies within our investment portfolio."
The Company's 2024 Annual Report will shortly be posted to shareholders together with a Notice of Annual General Meeting, copies of which will be made available on the Company's website at www.adamsplc.co.uk under the Investor Relations / Company & Shareholder Documents section. The Annual General Meeting is to be held at
This announcement contains inside information as defined in Article 7 of the Market Abuse Regulation No. 596/2014 ("MAR") as retained as part of
Enquiries:
Adams Plc
Nomad Cairn Financial Advisers LLP. Sandy Jamieson, James Caithie Tel: +44 207 213 0880
Broker Peterhouse Capital Limited. Heena Karani, Martin Lampshire Tel: +44 207 469 0930
Chairman's Statement
Adams generated a net loss of
That loss for the year of
During the year, the Company spent
The carrying value of the Company's equity investments at
The Company held cash balances of
Net assets decreased to
Business model and investing policy
Adams is an investing company with an investing policy under which the Board is seeking to acquire interests in special situation investment opportunities that have an element of distress, dislocation, dysfunction or other special situation attributes and that the Board perceives to be undervalued. The principal focus is in the small to middle-market capitalisation sectors in the UK or Europe, but the Directors will also consider possible special situation opportunities anywhere in the world if they believe there is an opportunity to generate added value for shareholders.
Investment Portfolio
The principal listed investments held by the Company at
Niox is an AIM listed global medical device company focused on point of care asthma diagnosis and management. Niox is a debt-free business with a strong NIOX® asthma management products-based business. The company is continuing its growth as a distributor-led business implementing access to a large and underserved population of patients suffering from asthma. All three of its key geographic areas of Asia Pacific, EU and USA generated profitable growth in the 2023 year. Niox is also making good progress in expanding sales into the UK primary care sector and where the NHS is supporting the use of FeNO testing using NIOX devices. For the year ended
Seeing Machines is an AIM listed industry leader in advanced computer vision technologies. The company designs Artificial Intelligence / AI powered operator monitoring systems using camera-based optics and embedded processing to improve transport safety in automotive, commercial fleet, aviation, rail and off-road markets. The technology incorporates warnings when human state attention impairment is identified, in order to re-engage the operator or driver. Seeing Machines continues to invest in R&D and grow as an automotive leader in such technology having now won contracts with a total of 11 automotive Tier 1 global customers covering 17 automotive driver monitoring safety ("DMS") programmes with a combined initial lifetime value of
Griffin, is an AIM listed mining and investment company that has been the leader in foreign investment in mining in China having been engaged in developing the Caijiaying zinc and gold project since 1997. In
Pulsar is an AIM listed London based technology innovator delivering Artificial Intelligence / AI Software-as-a-Service solutions for the global marketing and communications industries. The company combines AI technologies with human expertise to analyse data and provide strategic insights as a single, real-time view of what is important. It is supported by partnerships with the world's largest data providers and social media platforms including X (formerly Twitter), Reddit and Twitch. For the year ended
NCC is an FTSE All-Share listed global tech-enabled cyber and software resilience business operating across multiple sectors, geographies and technologies. The company advises global technology, manufacturers, financial institutions, critical national infrastructure providers, retailers and governments on the best way to keep businesses, software and personal data safe and provides solutions to manage all manner of cyber threats. The last 12 months has seen the company transitioning from a business operating internationally to becoming a truly global organisation and which has included the recent opening of its new office in Manila, the Philippines, alongside the creation of further universal processes within its technology platform. For the 6-month half year ended
C4XD is a private pioneering drug discovery company combining its enhanced DNA-based target identification and candidate molecule design capabilities to efficiently deliver world‑leading medicines which are developed by licensing partners. C4XD has a number of existing partnership deals including a milestone and royalties out-licensing agreement with Sanofi for its IL-17A inhibitor programme worth up to
Oxehealth is a private company and an industry leader in vision-based patient monitoring and management systems. The company uses proprietary signal processing and computer vision to process normal digital video camera data to measure the vital signs and activity of patients in a number of different markets in the UK, Sweden and more recently also the USA. This is achieved through the deployment of its Oxevision platform which provides customer staff with a wider range of contact-free location and activity-based alerts, reports and vital signs measurements than any other technology, plus the ability to check the patient visually if needed to support on-the-spot decision making. This enables customers to create proactive, data-enabled systems of care that help deliver year on year continuous improvement in safety, quality and efficiency. In
Telit is a private company and a global leader in Internet of Things (IoT) enablement. Telit has over twenty years of experience designing, building, and executing complex digital business. The company has an extensive portfolio of wireless connectivity modules, software platforms and global IoT connectivity services, empowering hundreds of millions of connected 'things' to date, and trusted by thousands of direct and indirect customers, globally. These IoT devices include industrial handhelds, utility meters, industrial and agricultural environmental sensors, health monitors, industrial robots, CNC machines, cameras and many more factory floor devices, as well as wearables and precision mobile trackers. Telit's plug-and-play solutions connect industrial IoT applications with minimal integration effort and its gateways provide host devices with convenient access to the internet via cellular connectivity as well as using IoT Wi-Fi and Bluetooth technology as appropriate for certain market segments, including connected home, wearables, automobiles and smart buildings. Telit's IoT platforms also enable AI and machine learning to be incorporated into customer applications, including visual inspection and object recognition. On
In addition to the above investments, at
Outlook
Headline inflation fell rapidly in most economies during 2023, driven down by restrictive monetary policy settings, lower energy prices and continued easing of supply chain pressures. There are signs that the global economic outlook has started to brighten although growth is expected to remain modest during 2024 amid high levels of government debt and with interest rate cuts expected to be incremental and moderate as major central banks balance the final mile of getting inflation back to target rates.
Elevated trade tensions with China, the ongoing Russia-Ukraine war and conflicts in the Middle East all point to continued uncertainties and risks going forward. In addition, many governments continue to face mounting fiscal challenges from rising debt service costs and sizeable additional spending pressures from ageing populations, climate change mitigation and increased defence spending in the face of growing geopolitical discord.
In view of the above risks and uncertainties, your Board will continue to maintain a rigorous and highly selective investment approach, coupled with strict cost control with a view to delivering additional value for shareholders going forward. We remain confident in the underlying fundamentals, technologies and long-term potential for growth at the companies within our investment portfolio.
Michael Bretherton
Chairman
Investing Policy
The current Investing Policy is:
The Board will seek to acquire a direct and/or indirect interests in special situation investment opportunities that have an element of distress, dislocation, dysfunction or other special situation attributes and that they perceive to be undervalued. The principal focus will be in the small to middle-market capitalisation sectors in the UK or Europe but the Directors will also consider possible special situation opportunities anywhere in the world if they believe there is an opportunity to generate added value for Shareholders.
The Directors intend to identify investment opportunities offering the potential to deliver a favourable return to Shareholders over the medium to long term, primarily in the form of a capital gain. A particular consideration will be to identify businesses which, in the opinion of the Directors, are under-valued due to any of a number of special situations that adversely impact the business's short-term prospects and/or underlying value but which business interests the Directors believe have a solid fundamental core or sound development potential to present opportunities for value creation.
The Company's interest in a potential investment may range from a minority position to 100 per cent. ownership and the interest may be either quoted or unquoted. Investments may be made in shares, or by the acquisition of assets (including intellectual property) of a relevant business, or by entering into partnerships, joint ventures, equity derivatives, contracts for differences or other equity or debt related securities that the Board deem appropriate.
There will be no limit on the number of projects into which the Company may invest, and the Company's financial resources may be invested in a number of propositions or in just one investment, which may be deemed to be a reverse takeover pursuant to Rule 14 of the AIM Rules.
While the Directors intend to take into account the level of existing funds available for investment when assessing the amount of any investment, it is not proposed that there be any maximum investment limit.
The Company may be both an active and a passive investor depending on the nature of the individual investments. Although the Company intends to be a medium to long term investor, there will be no minimum or maximum limit on the length of time that any investment may be held and short-term investments may be made.
The Company will not have a separate investment manager.
The Company may require additional funding as investments are made and new opportunities arise. The Directors may offer new Ordinary Shares by way of consideration, as well as cash, thereby helping to preserve the Company's cash resources. The Company may, in appropriate circumstances, issue debt securities or otherwise borrow money to complete an investment.
Given the nature of the Company's Investing Policy, the Company does not intend to make regular periodic disclosures or calculations of net asset value other than at the time of publication of its half year and annual results.
The Board's principal focus will be on achieving capital growth for Shareholders.
Statement of Comprehensive Income for the year ended
|
|
|
Year ended |
Year ended |
|
|
|
£'000 |
£'000 |
|
Dividend income |
|
49 |
- |
|
Profit/(loss) on investments |
|
18 |
(2,188) |
|
Investment return/(loss) |
|
67 |
(2,188) |
|
Expenses and other income |
|
|
|
|
Administrative expenses |
|
(195) |
(182) |
|
Operating loss |
|
(128) |
(2,370) |
|
Interest income |
|
1 |
- |
|
Loss on ordinary activities before taxation |
|
(127) |
(2,370) |
|
Tax on loss on ordinary activities |
|
- |
- |
|
Loss for the year |
|
(127) |
(2,370) |
|
Basic and diluted loss per share |
|
(0.09)p |
(1.62)p |
Statement of Financial Position at
|
|
|
|
|
31 March 2023 |
|
|
|
£'000 |
|
£'000 |
|
Assets |
|
|
|
|
|
Non-current assets |
|
|
|
|
|
Investments |
|
4,934 |
|
5,095 |
|
Current assets |
|
|
|
|
|
Trade and other receivables |
|
12 |
|
11 |
|
Cash and cash equivalents |
|
87 |
|
47 |
|
Current assets |
|
99 |
|
58 |
|
Total assets |
|
5,033 |
|
5,153 |
|
Liabilities |
|
|
|
|
|
Current liabilities |
|
|
|
|
|
Trade and other payables |
|
(50) |
|
(43) |
|
Total liabilities |
|
(50) |
|
(43) |
|
Net current assets |
|
49 |
|
15 |
|
Net assets |
|
4,983 |
|
5,110 |
|
|
|
|
|
|
|
Equity |
|
|
|
|
|
Share capital |
|
1,459 |
|
1,459 |
|
Share premium |
|
3,425 |
|
3,425 |
|
Retained earnings reserve |
|
99 |
|
226 |
|
Total shareholder equity |
|
4,983 |
|
5,110 |
Statement of Changes in Equity as at
|
|
|
Share Capital |
Share premium |
Retained earnings reserve |
Total |
|
|
|
£'000 |
£'000 |
£'000 |
£'000 |
|
At |
|
1,459 |
3,425 |
2,596 |
7,480 |
|
Changes in equity |
|
|
|
|
|
|
Total comprehensive loss |
|
- |
- |
(2,370) |
(2,370) |
|
At |
|
1,459 |
3,425 |
226 |
5,110 |
|
Changes in equity |
|
|
|
|
|
|
Total comprehensive loss |
|
- |
- |
(127) |
(127) |
|
At |
|
1,459 |
3,425 |
99 |
4,983 |
Statement of Cash Flows for the year ended
|
|
|
|
|
|
|
|
|
Year ended |
|
Year ended |
|
|
|
|
|
*Restated |
|
|
|
£'000 |
|
£'000 |
|
Loss for the year |
|
(127) |
|
(2,370) |
|
|
|
|
|
|
|
Unrealised loss on revaluation of portfolio investments |
|
1 |
|
2,203 |
|
Realised gain on disposal of portfolio investments |
|
(19) |
|
(15) |
|
(Increase)/decrease in trade and other receivables |
|
(1) |
|
1 |
|
Increase in trade and other payables |
|
7 |
|
18 |
|
Net cash outflow from operating activities |
|
(139) |
|
(163) |
|
Cash flows from investing activities |
|
|
|
|
|
Purchase of portfolio investments |
|
(211) |
|
(1,216) |
|
Proceeds from sales of investments |
|
390 |
|
555 |
|
Net cash generated/(used) in investing activities |
|
179 |
|
(661) |
|
Net increase/(decrease) in cash and cash equivalents |
|
40 |
|
(824) |
|
Cash and cash equivalents at beginning of year |
|
47 |
|
871 |
|
Cash and cash equivalents at end of year |
|
87 |
|
47 |
|
|
|
|
|
|
Caution regarding forward looking statements
Certain statements in this announcement, are, or may be deemed to be, forward looking statements. Forward looking statements are identified by their use of terms and phrases such as ''believe'', ''could'', "should" ''envisage'', ''estimate'', ''intend'', ''may'', ''plan'', ''potentially'', "expect", ''will'' or the negative of those, variations or comparable expressions, including references to assumptions. These forward-looking statements are not based on historical facts but rather on the Directors' current expectations and assumptions regarding the Company's future growth, results of operations, performance, future capital and other expenditures (including the amount, nature and sources of funding thereof), competitive advantages, business prospects and opportunities. Such forward looking statements reflect the Directors' current beliefs and assumptions and are based on information currently available to the Directors.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Proactive Investors is a publisher of financial news and information. No content in this record, or published on the Proactive Investors website (the "Site"), constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. No content is tailored to any specific person's needs, objectives, or financial situation.
Proactive Investors is not a registered investment adviser or broker-dealer and does not provide personalized investment advice. Nothing in this record constitutes investment advice or a recommendation to buy, hold, or sell any security. None of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value, or suitability of any particular security, portfolio, transaction, or investment strategy. Any decision to buy, sell, or hold a security should be made only after consulting an appropriately qualified, licensed financial adviser and reading all relevant offering documentation.
This record, and any record we publish by or on behalf of our clients, should not be construed as an offer or solicitation to buy or sell any product or security. Our content is independent financial journalism, produced in a neutral, objective style with full source attribution.
In accordance with the Federal Trade Commission's guidelines on material connections, Proactive Investors discloses the following: we may receive cash or, in some cases, equity compensation from companies whose news is distributed through our platform. This compensation is for news distribution and media services, not for editorial content or coverage decisions. Where Proactive Investors has a commercial relationship with a company covered in this record, that relationship is disclosed within the article. Any such relationship does not determine, influence, or shape the editorial content produced. Where we receive equity compensation, such securities are held independently by a third-party broker and sold at the broker's discretion.
The Site may contain opinions from time to time regarding securities mentioned in other products, including company-related products, and those opinions may differ from those obtained through another Proactive Investors product. Opinions and commentary reflect the views of the named author at the time of writing and are subject to change without notice.
Price and other data is supplied by sources believed to be reliable. Any calculations are made using such data. Neither the data nor the calculations are guaranteed by those sources, by Proactive Investors, by the information providers, or by any other person or entity, and may not be complete or accurate.
From time to time, reference may be made in our marketing materials to previously published articles or opinions. Such references may be selective, may reference only a portion of an article, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.
FOR OUR FULL DISCLAIMER CLICK HERE